241
Views
0
CrossRef citations to date
0
Altmetric
Articles

Three new chromanes and one new flavone C-glycoside from Mallotus apelta

, , , , , , , , , , & show all
Pages 18-26 | Received 27 Nov 2021, Accepted 07 Mar 2022, Published online: 20 Mar 2022
 

Abstract

Three new chromanes, malloapeltas J–L (13), and one new flavone C-glycoside, malloflavoside (4), together with four known compounds, apigenin 6-C-β-D-xylopyranosyl-8-C-α-L-arabinopyranoside (5), apigenin 6-C-β-D-glucopyranosyl-8-C-α-L-arabinopyranoside (6), apigenin 7-O-β-D-apiofuranosyl-(1→2)-β-D-glucopyranoside (7), and acantrifoside E (8) were isolated from the methanol extract of the leaves of Mallotus apelta. Their chemical structures were determined using spectroscopic methods, including 1D, 2D NMR, and HR-ESI-MS methods. All the isolated compounds were evaluated their cytotoxic activity against human prostate cancer (PC-3) and human breast cancer (MCF-7) cells, but none of them showed cytotoxicities on both human cancer cell lines.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This research was financially supported by Vietnam Academy of Science and Technology (DL0000.01/19-20); The Ministry of Education, Science and Technology, Republic of Korea (Grant no. NRF-2021K2A9A1A06086013); and Korea Basic Science Institute (Grant no. C210300). High resolution mass data were obtained from Korea Basic Science Institute (KBSI, Chuncheon Center).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.